A High Content Clonogenic Survival Drug Screen Identifies MEK Inhibitors as Potent Radiation Sensitizers for KRAS Mutant Non–Small-Cell Lung Cancer

Autor: Lin, Steven H. *, *, Zhang, Jing *, Giri, Uma, Stephan, Clifford, Sobieski, Mary, Zhong, Ling, Mason, Kathy A., Molkentine, Jessica, Thames, Howard D., Yoo, Stephen S., Heymach, John V.
Zdroj: In Journal of Thoracic Oncology July 2014 9(7):965-973
Databáze: ScienceDirect